BioSpace News Archive

Supernus Pharmaceuticals, Inc. today announced that it expected to file its Annual Report on Form 10-K for the fiscal ended December 31, 2021 (the “Annual Report”) in the near term.

Fluidigm Corporation announced the closing of the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC and Viking Global Investors LP. Fluidigm has been renamed Standard BioTools Inc. and its common stock is expected to begin trading on Nasdaq under the symbol “LAB” as of the open of market on April 6, 2022.

Edward T. A. Fry, MD, FACC, begins his one-year term as president of the American College of Cardiology, a nonprofit cardiovascular medical society representing over 54,000 cardiologist and cardiovascular care team members around the world.

Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that it has closed the previously announced merger to acquire Precision Healing Inc.